MCPH Medical Cannabis Patients Hub Patient-first medical cannabis guidance for the UK

Patient guide

CBD for Arthritis: What the Evidence Says

CBD is not a proven routine treatment for arthritis; the evidence is mixed and NICE does not recommend it outside a clinical trial.

12 June 2026 4 min read min read

CBD is not a proven routine treatment for arthritis. For patients, the real question is whether it reliably helps, and whether it is worth trying. The short answer is that the evidence is still limited and mixed. NICE says not to offer CBD for chronic pain in adults unless it is part of a clinical trial.

Safety note: if you are pregnant or breastfeeding, take regular medicines, need to drive, or have a history of psychosis or bipolar disorder, speak to a clinician or pharmacist before trying CBD. Seek urgent help if a new product causes severe drowsiness, confusion, suicidal thoughts, or a clear change in mood or behaviour.

Key takeaways

  • The evidence for CBD in arthritis is limited and mixed.
  • Most human evidence is in osteoarthritis, and much of it is small or uses broader cannabis-based products rather than CBD alone.
  • One small single-centre trial of topical CBD for thumb basal joint arthritis reported improvement in pain-related outcomes, but that is not enough to support routine use.
  • CBD is not a cure for arthritis and should not replace standard treatment.
  • If a CBD product makes medicinal claims, the MHRA treats it as a medicine and expects medicinal standards to apply.

Evidence base

Most of the human evidence sits in osteoarthritis rather than arthritis as a whole. A 2024 scoping review of cannabis-based medicines in osteoarthritis found the evidence was mixed. Some studies reported pain improvement, but the studies were small, short, or too different to compare cleanly. The review concluded that the data were not strong enough to make a recommendation.

A 2024 systematic review of rheumatological diseases reached a similar conclusion. Cannabis has been studied in osteoarthritis, rheumatoid arthritis, and other conditions, but the evidence remains limited and uneven. That matters because patient-facing copy can easily blur "there are some promising studies" into "this works for arthritis". The evidence does not support that jump.

There is one useful nuance. A small randomised controlled trial of topical CBD for thumb basal joint arthritis reported better pain outcomes than placebo. That is promising, but it is still one small study at a specific joint and with a specific product. It does not prove that CBD will help most people with arthritis, or that oral CBD oils and gummies will do the same thing.

It is also worth separating CBD-only evidence from broader cannabis-based medicinal products. Registry studies of people using medical cannabis can show improvements in pain or sleep, but many of those products contain THC as well as CBD. They are not the same thing as CBD alone, so they cannot be used to make a strong CBD-only claim.

The safety picture is also incomplete. Short-term studies suggest CBD and cannabis-based products are often tolerated reasonably well, but the long-term balance of benefit and harm is still not clear. CBD can also interact with other medicines and may affect the liver, so it should not be treated as a low-risk self-care shortcut.

What patients should know

If you are thinking about CBD for arthritis, start with the outcome you want to change: pain, sleep, stiffness, function, or something else. That makes it easier to tell whether anything is actually helping.

A few practical points help keep expectations realistic:

  • Over-the-counter CBD oils, gummies, and capsules are not the same as a prescribed medicine.
  • Product quality can vary, and the amount of CBD or THC on the label may not match what is actually in the bottle.
  • NICE's recommendation is about cannabis-based medicinal products for chronic pain, not a green light for shop-bought CBD oils.
  • If a product claims to treat arthritis, the MHRA says it is being presented as a medicine.
  • CBD can interact with other medicines and may affect the liver, so it is not something to start casually if you already take regular treatment.
  • If you try it, agree in advance how you will judge benefit and when you will stop.

NHS guidance also makes an important point for patients: medical cannabis can sometimes help certain types of pain, but the evidence is not strong enough to recommend it for pain relief in routine care. That is a good reminder not to let marketing outpace the evidence.

When to speak to a clinician

Speak to a clinician or pharmacist before trying CBD if:

  • you take regular medicines, especially medicines with interaction risk
  • you have liver disease
  • you are pregnant or breastfeeding
  • you need to drive or operate machinery
  • you have anxiety, depression, psychosis, or other mental health concerns that could worsen with a new treatment
  • your arthritis pain is worsening or affecting sleep, work, or daily function
  • you are thinking about replacing prescribed arthritis treatment with CBD

Stop and seek medical advice if you notice drowsiness, diarrhoea, dizziness, appetite loss, mood change, or any other new side effects after starting CBD. If you develop severe confusion, suicidal thoughts, or another urgent health problem, seek urgent care.

Questions to ask a clinician

  • Is there a standard arthritis treatment that should be optimised before I think about CBD?
  • Could CBD interact with any of my current medicines or affect my liver?
  • If I try CBD, how will we judge whether it is helping, and when should I stop?

Source trail